Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=15492766&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Cardiovascular protective effects of resveratrol Bradamante S; Barenghi L; Villa ACardiovasc Drug Rev 2004[Fal]; 22 (3): 169-88Resveratrol (3,4',5-trihydroxy-trans-stilbene), a phytoalexin found in grape skins, peanuts, and red wine, has been reported to have a wide range of biological and pharmacological properties. It has been speculated that at low doses (such as consumed in the common diet) resveratrol may have cardioprotective activity. In this article we describe recent in vitro and in vivo studies in animal models. The results of these studies suggest that resveratrol modulates vascular cell function, inhibits LDL oxidation, suppresses platelet aggregation and reduces myocardial damage during ischemia-reperfusion. Although the reported biological data indicate that resveratrol is a highly promising cardiovascular protective agent, more studies are needed to establish its bioavailability and in vivo cardioprotective effects, particularly in humans.|Animals[MESH]|Antioxidants/administration & dosage/pharmacology/therapeutic use[MESH]|Cardiotonic Agents/administration & dosage/*pharmacology/therapeutic use[MESH]|Cardiovascular Diseases/prevention & control[MESH]|Cholesterol/blood[MESH]|Dose-Response Relationship, Drug[MESH]|Humans[MESH]|Lipid Peroxidation/drug effects[MESH]|Myocardial Reperfusion Injury/drug therapy[MESH]|Platelet Aggregation Inhibitors/administration & dosage/pharmacology/therapeutic use[MESH]|Resveratrol[MESH]|Stilbenes/administration & dosage/*pharmacology/therapeutic use[MESH]|Time Factors[MESH] |
